Annette Beck-Sickinger
#84,631
Most Influential Person Now
German biochemist
Annette Beck-Sickinger's AcademicInfluence.com Rankings
Annette Beck-Sickingerbiology Degrees
Biology
#6907
World Rank
#9723
Historical Rank
Biochemistry
#1088
World Rank
#1204
Historical Rank
Download Badge
Biology
Why Is Annette Beck-Sickinger Influential?
(Suggest an Edit or Addition)According to Wikipedia, Annette Gabriele Beck-Sickinger is a German chemist and biologist. She has been a full professor of Biochemistry and Bioorganic Chemistry at the University of Leipzig since 1999. Career Annette G. Beck-Sickinger studied chemistry and biology at the University of Tübingen and received her Ph.D. under the supervision of Günther Jung .
Annette Beck-Sickinger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. (1998) (879)
- GPR39 signaling is stimulated by zinc ions but not by obestatin. (2007) (399)
- The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. (1994) (348)
- Physiology: Does gut hormone PYY3–36 decrease food intake in rodents? (2004) (307)
- Cell Communication and Signaling (2009) (246)
- Multiple Peptide Synthesis Methods and Their Applications. New Synthetic Methods (87) (1992) (214)
- Molecular characterization of the ligand–receptor interaction of the neuropeptide Y family (2000) (190)
- Neuropeptide Y stimulates neuronal precursor proliferation in the post‐natal and adult dentate gyrus (2005) (188)
- Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. (1994) (175)
- The First Selective Agonist for the Neuropeptide YY5Receptor Increases Food Intake in Rats* (2000) (174)
- Neuropeptide Y is neuroproliferative for post‐natal hippocampal precursor cells (2003) (161)
- Automated solid-phase peptide synthesis to obtain therapeutic peptides (2014) (160)
- ESAG 6 and 7 products of Trypanosoma brucei form a transferrin binding protein complex. (1994) (153)
- Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. (2008) (144)
- Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells* (2003) (143)
- Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics. (2018) (142)
- Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects (2011) (135)
- Expressed protein ligation. Method and applications. (2004) (130)
- Processing, signaling, and physiological function of chemerin (2014) (128)
- Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation. (1997) (127)
- The anti‐epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors (2005) (125)
- Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. (2005) (122)
- PYY3‐36 as an anti‐obesity drug target (2005) (121)
- Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling (2011) (118)
- Neuropeptide Y receptors: how to get subtype selectivity (2013) (117)
- Vaspin inhibits kallikrein 7 by serpin mechanism (2013) (114)
- Peptides and peptide conjugates: therapeutics on the upward path. (2012) (112)
- Structure–activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors (1995) (111)
- Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. (2001) (110)
- In vivo characterization of high Basal signaling from the ghrelin receptor. (2009) (109)
- Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. (2002) (109)
- Peptide-tags for site-specific protein labelling in vitro and in vivo. (2016) (108)
- Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors (2010) (104)
- Cloning, expression, and sequencing of squalene-hopene cyclase, a key enzyme in triterpenoid metabolism (1992) (102)
- Action of derivatives of mu-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. (1992) (100)
- Epitope mapping of the Dermatophagoides pteronyssinus house dust mite major allergen Der p II using overlapping synthetic peptides. (1991) (99)
- Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: Activation by neuropeptide Y (2006) (97)
- Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. (1996) (96)
- Comparison of the photochemical behavior of four different photoactivatable probes. (2009) (95)
- In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. (2002) (94)
- Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. (1990) (93)
- Novel analogues of neuropeptide Y with a preference for the Y1-receptor. (2001) (93)
- Ghrelin Receptor Inverse Agonists: Identification of an Active Peptide Core and Its Interaction Epitopes on the Receptor (2006) (93)
- Peptide drugs to target G protein-coupled receptors. (2010) (91)
- Erratum: Does gut hormone PVY3-36 decrease food intake in rodents? (Nature (2004) 430 (165) DOI:10.1038/nature03019) (2004) (90)
- Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. (2002) (87)
- Receptor Subtype-specific Docking of Asp6.59 with C-terminal Arginine Residues in Y Receptor Ligands* (2007) (87)
- Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor (2018) (85)
- Peptides as carrier for tumor diagnosis and treatment. (2001) (81)
- Peptide αthioester formation using standard Fmoc-chemistry (2003) (81)
- Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies (2020) (78)
- Drug delivery and release systems for targeted tumor therapy (2015) (78)
- Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation (2008) (77)
- Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues. (2007) (77)
- Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism* (2007) (76)
- Molecular recognition of the NPY hormone family by their receptors. (2008) (74)
- Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). (2004) (74)
- A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. (1998) (73)
- Illuminating the life of GPCRs (2009) (72)
- Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands. (2004) (71)
- Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development (2011) (70)
- Developing novel hCT derived cell-penetrating peptides with improved metabolic stability. (2006) (69)
- Long-acting lipidated analogue of human pancreatic polypeptide is slowly released into circulation. (2011) (69)
- Breast-cancer diagnosis by neuropeptide Y analogues: from synthesis to clinical application. (2010) (69)
- Isotope-labeled cross-linkers and fourier transform ion cyclotron resonance mass spectrometry for structural analysis of a protein/peptide complex (2006) (68)
- Unwinding of the C-Terminal Residues of Neuropeptide Y is critical for Y₂ Receptor Binding and Activation. (2015) (68)
- Neuropeptide Y (NPY) Suppresses Experimental Autoimmune Encephalomyelitis: NPY1 Receptor-Specific Inhibition of Autoreactive Th1 Responses In Vivo 1 (2003) (66)
- Analogues of neuropeptide Y containing beta-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor. (2003) (65)
- Artificial chemokines: combining chemistry and molecular biology for the elucidation of interleukin-8 functionality. (2008) (63)
- Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus. (2008) (62)
- RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential (2011) (61)
- A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. (2012) (61)
- Multiple NPY Receptors Inhibit GABAA Synaptic Responses of Rat Medial Parvocellular Effector Neurons in the Hypothalamic Paraventricular Nucleus. (2002) (61)
- Incorporation of ortho-carbaboranyl-Nε-modified L-lysine into neuropeptide Y receptor Y1- and Y2-selective analogues. (2011) (60)
- Structural characterization and binding sites of G-protein-coupled receptors (1996) (60)
- From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. (1998) (59)
- Cellular Uptake But Low Permeation of Human Calcitonin-Derived Cell Penetrating Peptides and Tat(47-57) Through Well-Differentiated Epithelial Models (2004) (58)
- A novel cyclic analog of neuropeptide Y specific for the Y2 receptor. (1992) (58)
- Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. (2003) (57)
- Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. (1997) (56)
- Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors (2005) (55)
- Role of a hydrophobic pocket of the human Y1 neuropeptide Y receptor in ligand binding (1995) (54)
- Peptide-templated acyl transfer: a chemical method for the labeling of membrane proteins on live cells. (2014) (54)
- Multifunctional Coating Improves Cell Adhesion on Titanium by using Cooperatively Acting Peptides. (2016) (53)
- Novel chemically modified analogues of neuropeptide Y for tumor targeting. (2008) (52)
- Ghrelin receptor: high constitutive activity and methods for developing inverse agonists. (2010) (52)
- Blockade of neuropeptide Y2 receptors and suppression of NPY's anti‐epileptic actions in the rat hippocampal slice by BIIE0246 (2002) (52)
- Neuropeptide Y: identification of the binding site. (2009) (51)
- Cellular Internalization of Enhanced Green Fluorescent Protein Ligated to a Human Calcitonin‐Based Carrier Peptide (2002) (51)
- Amino Acid Side Chain Attachment Approach and Its Application to the Synthesis of Tyrosine-Containing Cyclic Peptides (1999) (51)
- Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26) (2002) (51)
- Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement. (2013) (50)
- Ghrelin—a novel generation of anti‐obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues (2009) (50)
- Structure and dynamics of helix-0 of the N-BAR domain in lipid micelles and bilayers. (2008) (49)
- Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. (2000) (49)
- Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery. (2016) (49)
- Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. (2009) (49)
- The Adipocytokine Nampt and Its Product NMN Have No Effect on Beta-Cell Survival but Potentiate Glucose Stimulated Insulin Secretion (2013) (48)
- Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. (2008) (48)
- Adrenomedullin – new perspectives of a potent peptide hormone (2017) (48)
- New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. (2007) (47)
- Synthetic S‐(2,3‐dihydroxypropyl)‐cysteinyl peptides derived from the N‐terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation (1995) (47)
- Y1 receptors in the nucleus accumbens: Ultrastructural localization and association with neuropeptide Y (1998) (47)
- Unique Interaction Pattern for a Functionally Biased Ghrelin Receptor Agonist* (2011) (47)
- Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland (2001) (47)
- Microscopic mechanism of specific peptide adhesion to semiconductor substrates. (2010) (46)
- NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization (2002) (46)
- Structure/activity relationships of C-terminal neuropeptide Y peptide segments and analogues composed of sequence 1-4 linked to 25-36. (1990) (46)
- Cellular Internalization of Human Calcitonin Derived Peptides in MDCK Monolayers: A Comparative Study with Tat(47-57) and Penetratin(43-58) (2004) (46)
- An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor. (2012) (46)
- Promiscuous Modification of the Nuclear Poly(A)-binding Protein by Multiple Protein-arginine Methyltransferases Does Not Affect the Aggregation Behavior* (2008) (45)
- Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs (2003) (45)
- Receptor‐Mediated Uptake of Boron‐Rich Neuropeptide Y Analogues for Boron Neutron Capture Therapy (2015) (44)
- Peptide mini-scaffold facilitates JNK3 activation in cells (2016) (44)
- 2–36[K4,RYYSA19–23]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake (2000) (43)
- Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands. (2006) (43)
- Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively* (2009) (43)
- Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue (2004) (43)
- Specifically Immobilised Aldo/Keto Reductase AKR1A1 Shows a Dramatic Increase in Activity Relative to the Randomly Immobilised Enzyme (2007) (42)
- Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist. (2008) (42)
- Optimization of capillary electrophoresis of mixtures of basic peptides and comparison with HPLC. (1993) (42)
- Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. (2014) (41)
- Biosynthesis of peptide hormones derived from precursor sequences. (2004) (40)
- Ligand-induced Internalization and Recycling of the Human Neuropeptide Y2 Receptor Is Regulated by Its Carboxyl-terminal Tail* (2010) (40)
- Structure–Activity Studies of RFamide Peptides Reveal Subtype‐Selective Activation of Neuropeptide FF1 and FF2 Receptors (2011) (38)
- Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor. (2019) (37)
- Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y5-receptor ligands with picomolar affinity (2001) (37)
- Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach. (2013) (37)
- In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. (2004) (36)
- Dimerization of adiponectin receptor 1 is inhibited by adiponectin (2010) (36)
- Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. (2006) (36)
- Calcitonin-derived peptide carriers: mechanisms and application. (2008) (36)
- Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor (1996) (36)
- The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor* (2008) (36)
- First selective agonist of the neuropeptide Y1‐receptor with reduced size (2009) (36)
- Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y2 receptors (2007) (36)
- Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. (2005) (35)
- Vaspin – a link of obesity and psoriasis? (2012) (35)
- Peptide modifications differentially alter G protein-coupled receptor internalization and signaling bias. (2014) (35)
- Multifunctional biomaterial coatings: synthetic challenges and biological activity (2017) (35)
- Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. (2002) (35)
- Electron paramagnetic resonance backbone dynamics studies on spin‐labelled neuropeptide Y analogues (2002) (34)
- Biocompatible silicon surfaces through orthogonal click chemistries and a high affinity silicon oxide binding peptide. (2012) (34)
- Determination of Affinity and Activity of Ligands at the Human Neuropeptide Y Y4 Receptor by Flow Cytometry and Aequorin Luminescence (2007) (34)
- The neuropeptide Y monomer in solution is not folded in the pancreatic‐polypeptide fold (2002) (34)
- Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors (2013) (33)
- A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y* (2002) (32)
- Anti-Inflammatory Action of Keratinocyte-Derived Vaspin: Relevance for the Pathogenesis of Psoriasis. (2016) (32)
- A reconstitution protocol for the in vitro folded human G protein-coupled Y2 receptor into lipid environment. (2010) (32)
- Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding. (2005) (32)
- Novel daunorubicin‐carrier peptide conjugates derived from human calcitonin segments (2003) (32)
- Large scale modification of biomolecules using immobilized sortase A from Staphylococcus aureus. (2013) (31)
- A rational approach for the development of reduced‐size analogues of neuropeptide Y with high affinity to the Y1 receptor (1995) (31)
- Asborin Inhibits Aldo/Keto Reductase 1A1 (2011) (31)
- Tracking of human Y receptors in living cells—A fluorescence approach (2007) (31)
- Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization. (2009) (31)
- Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET. (2015) (31)
- Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging. (2012) (30)
- Expressed enzymatic ligation for the semisynthesis of chemically modified proteins. (2003) (30)
- Controlling Toxicity of Peptide–Drug Conjugates by Different Chemical Linker Structures (2015) (30)
- GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system. (2008) (29)
- Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor (1998) (29)
- Generation of Carrier Peptides for the Delivery of Nucleic Acid Drugs in Primary Cells (2008) (29)
- Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes (2013) (29)
- Radiometal targeted tumor diagnosis and therapy with peptide hormones. (2008) (29)
- Nano-high-performance liquid chromatography in combination with nano-electrospray ionization Fourier transform ion-cyclotron resonance mass spectrometry for proteome analysis. (2003) (29)
- Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). (2005) (29)
- Sulfonation of arginine residues as side reaction in Fmoc-peptide synthesis. (2009) (28)
- Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study. (2004) (28)
- Inhibition of Kallikrein‐Related Peptidases 7 and 5 by Grafting Serpin Reactive‐Center Loop Sequences onto Sunflower Trypsin Inhibitor‐1 (SFTI‐1) (2016) (28)
- Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential (2016) (28)
- On the synthesis of orexin A: a novel one‐step procedure to obtain peptides with two intramolecular disulphide bonds (2000) (28)
- Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. (1992) (27)
- α‐Helical small molecular size analogues of neuropeptide Y: Structure‐activity relationships (1991) (27)
- Structural properties of orexins for activation of their receptors (2006) (27)
- Matrix metalloproteinase 9 (MMP-9) mediated release of MMP-9 resistant stromal cell-derived factor 1α (SDF-1α) from surface modified polymer films. (2014) (27)
- Membrane interaction of neuropeptide Y detected by EPR and NMR spectroscopy. (2005) (27)
- Microelectrode chip based real time monitoring of vital MCF-7 mamma carcinoma cells by impedance spectroscopy. (2008) (26)
- Selective neuropeptide Y conjugates with maximized carborane loading as promising boron delivery agents for boron neutron capture therapy. (2020) (26)
- CGRP 27–37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay (1999) (26)
- A stable meta‐carborane enables the generation of boron‐rich peptide agonists targeting the ghrelin receptor (2018) (26)
- A novel type of macrothrombocytopenia associated with a defect in α2,3-sialylation. (2011) (25)
- Inhibition of Ca2+channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue (1995) (25)
- Double Methotrexate-Modified Neuropeptide Y Analogues Express Increased Toxicity and Overcome Drug Resistance in Breast Cancer Cells. (2016) (25)
- Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptor. (2002) (25)
- Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands (2001) (25)
- Semisynthesis and Application of Carboxyfluorescein-Labelled Biologically Active Human Interleukin-8 (2003) (25)
- Pancreatic Polypeptide Is Recognized by Two Hydrophobic Domains of the Human Y4 Receptor Binding Pocket* (2013) (25)
- Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats. (2012) (24)
- Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide (2021) (24)
- The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor. (2002) (24)
- Facile and selective nanoscale labeling of peptides in solution by using photolabile protecting groups. (2003) (24)
- Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist (1996) (24)
- Live cell PNA labelling enables erasable fluorescence imaging of membrane proteins (2020) (24)
- Slime protein profiling: a non-invasive tool for species identification in Onychophora (velvet worms) (2014) (24)
- Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues. (2004) (23)
- Prokaryotic expression, in vitro folding, and molecular pharmacological characterization of the neuropeptide Y receptor type 2 (2009) (23)
- Palmitoylated SDF1 α Shows Increased Resistance against Proteolytic Degradation in Liver Homogenates (2011) (23)
- Charge‐Compensated Metallacarborane Building Blocks for Conjugation with Peptides (2016) (23)
- A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways*♦ (2016) (23)
- A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor (2004) (23)
- Residue 75 of Interleukin‐8 is Crucial for its Interactions with Glycosaminoglycans (2012) (22)
- A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy. (2019) (22)
- Different mode of arrestin-3 binding at the human Y1 and Y2 receptor. (2018) (22)
- Photoactivatable chemokines--controlling protein activity by light. (2013) (22)
- Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C‐terminal NPY analogues (1996) (22)
- Molecular ligand-receptor interaction of the NPY/PP peptide family. (2006) (22)
- Rapid Covalent Fluorescence Labeling of Membrane Proteins on Live Cells via Coiled-Coil Templated Acyl Transfer. (2015) (22)
- Molecular characterization of the ligand-receptor interaction of neuropeptide Y. (1999) (22)
- Probing of the neuropeptide Y-Y1-receptors interaction with anti-receptor antibodies. (1998) (22)
- Localization of Novel Adiponectin Receptor Constructs (2006) (21)
- The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites. (2016) (21)
- Endothelialization of titanium surfaces by bio-inspired cell adhesion peptide coatings. (2019) (21)
- Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes. (1997) (21)
- Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation (2015) (21)
- Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1–7), NPY(19–23), Ala31, Aib32, Gln34]hPP (2004) (21)
- Expressed Protein Ligation: Method and Applications (2004) (21)
- Toward the application of proteomics to human thyroid tissue. (2006) (21)
- Position and Length of Fatty Acids Strongly Affect Receptor Selectivity Pattern of Human Pancreatic Polypeptide Analogues (2014) (20)
- Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability. (2016) (20)
- Biophysical methods to study ligand-receptor interactions of neuropeptide Y. (2001) (20)
- Peptide-Mediated Specific Immobilization of Catalytically Active Cytochrome P450 BM3 Variant. (2016) (20)
- The effect of interleukin‐8 truncations on its interactions with glycosaminoglycans (2018) (20)
- Conformational and epitope mapping of herpes-simplex-virus type-1 thymidine kinase using synthetic peptide segments. (1991) (20)
- Automated Solid‐Phase Peptide Synthesis to Obtain Therapeutic Peptides (2015) (19)
- Antibody binding to a collagen type‐II epitope gives rise to an inhibitory peptide for autoreactive T cells (1992) (19)
- G Protein Preassembly Rescues Efficacy of W6.48 Toggle Mutations in Neuropeptide Y2 Receptor (2018) (19)
- Selective mode of action of guanidine-containing non-peptides at human NPFF receptors. (2012) (19)
- Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization. (2010) (19)
- Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors. (2000) (19)
- Posttranslational Modification of Proteins. Expanding Nature's Inventory. By Christopher T. Walsh. (2006) (19)
- Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates (2020) (19)
- BIBP 3226, a potent and selective neuropeptide Y Y1-receptor antagonist. Structure-activity studies and localization of the human Y1 receptor binding site (1997) (19)
- A Fast and Inexpensive Method for N‐Terminal Fluorescein‐Labeling of Peptides. (1998) (18)
- Simultaneous “One Pot” Expressed Protein Ligation and CuI‐Catalyzed Azide/Alkyne Cycloaddition for Protein Immobilization (2011) (18)
- Fluorescently labeled adrenomedullin allows real‐time monitoring of adrenomedullin receptor trafficking in living cells (2015) (18)
- Syntheses of defined sulfated oligohyaluronans reveal structural effects, diversity and thermodynamics of GAG–protein binding† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc03649g (2018) (18)
- On the Role of Thymopoietins in Cell Proliferation. Immunochemical Evidence for New Members of the Human Thymopoietin Family (1999) (18)
- Molecular characterization of the human neuropeptide Y Y2-receptor. (1999) (18)
- Sulfated hyaluronan attenuates inflammatory signaling pathways in macrophages involving induction of antioxidants (2017) (18)
- Oxidative in vitro folding of a cysteine deficient variant of the G protein-coupled neuropeptide Y receptor type 2 improves stability at high concentration (2013) (18)
- Semiautomated T-bag peptide synthesis using 9-fluorenyl-methoxycarbonyl strategy and benzotriazol-1-yl-tetramethyl-uronium tetrafluoroborate activation. (1991) (17)
- Identification of a potential modification site in human stromal cell-derived factor-1. (2010) (17)
- Semisynthesis and Characterization of the First Analogues of Pro‐Neuropeptide Y (2003) (17)
- Pyridone dipeptide backbone scan to elucidate structural properties of a flexible peptide segment. (2008) (17)
- High-affinity analogues of neuropeptide Y containing conformationally restricted non-proteinogenic amino acids. (1994) (17)
- Bioorthogonal Labeling of Ghrelin Receptor to Facilitate Studies of Ligand-Dependent Conformational Dynamics. (2015) (17)
- Proteome analysis to study signal transduction of G protein-coupled receptors. (2006) (17)
- Expression, Functional Characterization, and Solid-State NMR Investigation of the G Protein-Coupled GHS Receptor in Bilayer Membranes (2017) (17)
- The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer Membranes (2020) (17)
- Improved in Vitro Folding of the Y2 G Protein-Coupled Receptor into Bicelles (2018) (17)
- Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1–17, Ala31, Aib32]NPY (2003) (16)
- Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor. (2013) (16)
- Peptide backbone conformation affects the substrate preference of protein arginine methyltransferase I. (2012) (16)
- Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line (2000) (16)
- Tetrafunctional photoaffinity labels based on Nakanishi's m-nitroalkoxy-substituted phenyltrifluoromethyldiazirine. (2002) (16)
- Multifunctional coatings combining bioactive peptides and affinity-based cytokine delivery for enhanced integration of degradable vascular grafts. (2020) (16)
- Characterisation of G-protein-coupled receptors by antibodies. (2000) (16)
- Carbaboranes – more than just phenyl mimetics (2015) (16)
- The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. (1997) (16)
- Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization. (2019) (15)
- High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry. (2015) (15)
- The selective neuropeptide Y Y5 agonist [cPP1–7,NPY19–23,Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat (2012) (15)
- Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability. (2007) (15)
- Integrating Solid-State NMR and Computational Modeling to Investigate the Structure and Dynamics of Membrane-Associated Ghrelin (2015) (15)
- Active contractions in single suspended epithelial cells (2013) (15)
- Time-Resolved Tracking of Separately Internalized Neuropeptide Y2 Receptors by Two-Color Pulse-Chase. (2018) (15)
- Natural and synthetic peptide pools: Characterization by sequencing and electrospray mass spectrometry (1993) (15)
- Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity. (2020) (14)
- Combinatorial strategies in biology and chemistry (2002) (14)
- From Transcription Profile to Expression: The Signaling Repertoire of the SK-N-MC Neuroepithelioma Cell-Line (2004) (14)
- NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression (2019) (14)
- Conformation and Aggregation of Selectively PEGylated and Lipidated Gastric Peptide Hormone Human PYY3-36. (2018) (14)
- Characterisation of Neuropeptide Y Receptor Subtypes by Synthetic NPY Analogues and by Anti-receptor Antibodies‡ (2001) (13)
- Two motifs with different function regulate the anterograde transport of the adiponectin receptor 1. (2012) (13)
- Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks. (2019) (13)
- Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear (2016) (13)
- Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors. (1999) (13)
- Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential (2020) (13)
- Chapter 6 – The importance of various parts of the NPY molecule for receptor recognition (1997) (13)
- On-resin Diels-Alder reaction with inverse electron demand: an efficient ligation method for complex peptides with a varying spacer to optimize cell adhesion. (2016) (13)
- Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. (2004) (13)
- Cluster properties of peptides on (100) semiconductor surfaces. (2006) (13)
- The first reporter gene assay on living cells (2002) (13)
- Investigations on different coupling reagents for the synthesis of a cyclopeptide analog of neuropeptide Y (1991) (13)
- The interaction of neuropeptide Y with negatively charged and zwitterionic phospholipid membranes (2009) (13)
- The anterograde transport of the human neuropeptide Y2 receptor is regulated by a subtype specific mechanism mediated by the C-terminus (2012) (13)
- Chemerin and Vaspin: Possible Targets to Treat Obesity? (2013) (13)
- Epitope mapping: synthetic approaches to the understanding of molecular recognition in the immune system. (1993) (12)
- Short-range cytokine gradients to mimic paracrine cell interactions in vitro. (2016) (12)
- Comparative analysis of the signaling capabilities of the insulin receptor-related receptor. (2005) (12)
- Imitation and modification of bioactive lead structures via integration of boron clusters (2012) (12)
- Surface‐Binding Peptide Facilitates Electricity‐Driven NADPH‐Free Cytochrome P450 Catalysis (2018) (12)
- G protein-coupled receptors, Tiina P. Iismaa, Trevor J. Biden, John Shine. Springer-Verlag (1995), 181, hard cover, ISBN: 1 57059 058 3 (1996) (12)
- Determination of G-protein–coupled receptor oligomerization by molecular brightness analyses in single cells (2021) (12)
- Key motif to gain selectivity at the neuropeptide Y5-receptor: structure and dynamics of micelle-bound [Ala31, Pro32]-NPY. (2002) (12)
- Structural basis for ligand recognition of the neuropeptide Y Y2 receptor (2021) (12)
- Cleavage kinetics and anchor linked intermediates in solid phase peptide amide synthesis. (2009) (12)
- Genetically encoded photocrosslinkers as molecular probes to study G-protein-coupled receptors (GPCRs). (2012) (12)
- Combinatorial chemistry on solid supports (2007) (12)
- High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice (2016) (11)
- A Venomics approach coupled to high-throughput toxin production strategies identifies the first venom-derived melanocortin receptor agonists. (2020) (11)
- A new approach to secondary structure evaluation: secondary structure prediction of porcine adenylate kinase and yeast guanylate kinase by CD spectroscopy of overlapping synthetic peptide segments. (1997) (11)
- Chemical modification of neuropeptide Y for human Y1 receptor targeting in health and disease (2019) (11)
- Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes (2004) (11)
- Quantitative impedimetric NPY-receptor activation monitoring and signal pathway profiling in living cells. (2015) (11)
- From Scientists to Scientists-Moving Angewandte into the Future. (2020) (11)
- Mapping of antigenic and immunogenic sites of Haemophilus influenzae outer membrane protein P6 using synthetic lipopeptides. (1994) (11)
- Structure–activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems (1998) (11)
- Tuning peptide affinity for biofunctionalized surfaces. (2013) (11)
- Selective labelling of stromal cell‐derived factor 1α with carboxyfluorescein to study receptor internalisation (2010) (11)
- Assessment of a fully active class A G protein-coupled receptor isolated from in vitro folding. (2011) (11)
- A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action. (2015) (10)
- Synthesis and Conformational Analysis by CD Spectroscopy of Lantibiotic Leader, Pro- and Pre-Peptides (1993) (10)
- Peptide binding and photo‐crosslinking to detergent solubilized and to reconstituted transporter associated with antigen processing (TAP) (1997) (10)
- Semi-synthesis of chemokines. (2014) (10)
- Discovery of Small-Molecule Modulators of the Human Y4 Receptor (2016) (10)
- Adiponectin receptor 1 interacts with both subunits of protein kinase CK2 (2011) (10)
- Comparison of antibodies directed against receptor segments of NPY-receptors. (1999) (10)
- Receptor‐Ligand Interaction (2005) (10)
- Identification and stabilization of a highly selective gastrin‐releasing peptide receptor agonist (2019) (10)
- Ligand-mimicking Receptor Variant Discloses Binding and Activation Mode of Prolactin-releasing Peptide* (2012) (9)
- Modulation of Human CXCL12 Binding Properties to Glycosaminoglycans To Enhance Chemotactic Gradients. (2019) (9)
- One-step procedure for staining of proteins with ruthenium II tris (bathophenanthroline disulfonate). (2007) (9)
- Peptides@mica: from affinity to adhesion mechanism. (2016) (9)
- The activity of prolactin releasing peptide correlates with its helicity. (2013) (9)
- Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging (2017) (9)
- An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins (2020) (9)
- A novel microfluidic microelectrode chip for a significantly enhanced monitoring of NPY-receptor activation in live mode. (2017) (9)
- Synthesis and application of peptides as drug carriers. (2009) (9)
- Calcitonin‐derived carrier peptide plays a major role in the membrane localization of a peptide–cargo complex (2004) (9)
- Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides (2020) (8)
- Fluorescence resonance energy transfer to study receptor dimerization in living cells. (2004) (8)
- Identification and Characterization of the First Selective Y4 Receptor Positive Allosteric Modulator. (2017) (8)
- Rational design of dual peptides targeting ghrelin and Y2 receptors to regulate food intake and body weight. (2015) (8)
- A rationally designed oligopeptide shows significant conformational changes upon binding to sulphate ions. (2001) (8)
- Site specific biotinylation of the human aldo/keto reductase AKR1A1 for immobilization (2004) (8)
- Photoinduced receptor confinement drives ligand-independent GPCR signaling (2021) (8)
- Modulatory effect of two novel CGRP receptor antagonists on nasal vasodilatatory responses to exogenous CGRP, capsaicin, bradykinin and histamine in anaesthetised pigs (2001) (8)
- Protein-backbone-modifications: Formation of imidazolines (2006) (7)
- Preparation of C-terminally modified chemokines by expressed protein ligation. (2013) (7)
- Peptide‐mediated surface coatings for the release of wound‐healing cytokines (2020) (7)
- Carbaboranylation of Truncated C‐Terminal Neuropeptide Y Analogue Leads to Full hY1 Receptor Agonism (2018) (7)
- Unusually persistent Gαi-signaling of the neuropeptide Y2 receptor depletes cellular Gi/o pools and leads to a Gi-refractory state (2020) (7)
- Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels (2013) (7)
- Ligand-binding and -scavenging of the chemerin receptor GPR1 (2021) (7)
- Cell-Free Expression and Photo-Crosslinking of the Human Neuropeptide Y2 Receptor (2019) (7)
- Characterization of the binding site of neuropeptide Y to the rabbit kidney receptor using multiple peptide synthesis. (1992) (7)
- Structure-activity relationship studies: methods and ligand design for G-protein coupled peptide receptors. (2006) (7)
- Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation (2019) (7)
- Expressed protein ligation for protein semisynthesis and engineering. (2005) (7)
- Identification of the dimerisation interface of human interleukin-8 by IL-8-variants containing the photoactivatable amino acid benzoyl-phenylalanine (2007) (7)
- Ubiquitin is a versatile scaffold protein for the generation of molecules with de novo binding and advantageous drug-like properties (2015) (7)
- Probing the Y2 Receptor on Transmembrane, Intra- and Extra-Cellular Sites for EPR Measurements (2020) (7)
- Functional characterization of the in vitro folded human y(1) receptor in lipid environment. (2010) (7)
- Novel Y2-selective, reduced-size agonists of neuropeptide Y (1993) (7)
- Calcitonin-derived carrier peptides. (2005) (7)
- Biased agonists at the human Y1 receptor lead to prolonged membrane residency and extended receptor G protein interaction (2020) (7)
- Multiple Peptide Synthesis Methods and Their Applications (2010) (7)
- New Members of the Editorial Board and International Advisory Board. (2018) (7)
- Intracellular Trafficking of Neuropeptide Y Receptors. (2015) (6)
- Advanced 96-microtiter plate based bioelectrochemical platform reveals molecular short cut of electron flow in cytochrome P450 enzyme. (2020) (6)
- On‐Resin Synthesis of an Acylated and Fluorescence‐Labeled Cyclic Integrin Ligand for Modification of Poly(lactic‐co‐glycolic acid) (2012) (6)
- Prenatal notch1 receptor blockade by protein delta homolog 1 (DLK1) modulates adipocyte size in vivo (2016) (6)
- Cyclic Analogues of the Chemerin C-Terminus Mimic a Loop Conformation Essential for Activating the Chemokine-like Receptor 1. (2021) (6)
- New Members of the Editorial Board and International Advisory Board. (2019) (6)
- Molecular tools to characterize adiponectin activity. (2012) (6)
- Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y. (1995) (6)
- Cyclopeptide analogs for characterization of the neuropeptide Y Y2-receptor. (1993) (6)
- Low potency inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by [Ala31]NPY, an l-alanine substituted analogue of neuropeptide Y (1995) (5)
- The Dynamics of the Neuropeptide Y Receptor Type 1 Investigated by Solid-State NMR and Molecular Dynamics Simulation (2020) (5)
- Energetic electron assisted synthesis of highly tunable temperature-responsive collagen/elastin gels for cyclic actuation: macroscopic switching and molecular origins (2019) (5)
- Tuning a modular system - synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety. (2019) (5)
- Secondary structure prediction of adenylate kinase by circular dichroism spectroscopy of synthetic peptides. (1995) (5)
- Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation. (2008) (5)
- Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors (2022) (5)
- Rapid fully automatic SMPS for epitope mapping of influenza nucleoprotein (1991) (5)
- In vitro modification of substituted cysteines as tool to study receptor functionality and structure-activity relationships. (2013) (5)
- The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor‐like Receptor/Receptor Activity‐Modifying Protein System (2018) (5)
- Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment (2021) (5)
- From Multiple Peptide Synthesis to Peptide Libraries (2007) (5)
- Structural investigations of cell-free expressed G protein-coupled receptors (2019) (4)
- Neuropeptide Y-induced mast cell activation. (1994) (4)
- Evaluation of the secondary structure of vaccinia-virus thymidine kinase by circular-dichroism spectroscopy of overlapping synthetic peptides. (1996) (4)
- Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges (2021) (4)
- Shuttling of Peptide‐Drug Conjugates by G Protein‐Coupled Receptors Is Significantly Improved by Pulsed Application (2020) (4)
- A Deep Hydrophobic Binding Cavity is the Main Interaction for Different Y2R Antagonists (2017) (4)
- Characterisation of Neuropeptide Y Receptor Subtypes by Synthetic NPY Analogues and by Anti-receptor Antibodies (2000) (4)
- Reporter Gene Assay Systems for the Investigation of G‐protein‐coupled Receptors (2005) (4)
- C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment. (2017) (4)
- Investigation of the Influence Glycosaminoglycan Sulfation on the Interaction with Interleukin-8 by Fluorescence and Solution NMR Spectroscopy (2012) (4)
- Expressed protein ligation to obtain selectively modified aldo/keto reductases. (2005) (4)
- Strategies for Site‐Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags (2021) (4)
- Multiple Peptide Synthesis to Identify Bioactive Hormone Structures (2007) (3)
- Towards Understanding the Free and Receptor Bound Conformation of Neuropeptide Y by Fluorescence Resonance Energy Transfer Studies (2009) (3)
- Semisynthesis and Characterization of the First Analogues of Pro‐Neuropeptide Y. (2003) (3)
- The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors (2021) (3)
- Development of a ghrelin receptor inverse agonist for positron emission tomography (2021) (3)
- Introducing… Advisory Editors and New Author Profiles at Angewandte Chemie. (2021) (3)
- Synthesis of conformationally restricted peptides. (1997) (3)
- Retro-inverso analogs of neuropeptide Y (1993) (3)
- Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite (2021) (3)
- Sialyltransferase ST3Gal-IV controls fi rm leukocyte arrest during infl ammation (2008) (3)
- C‐terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism (2016) (3)
- New Boron Delivery Agents. (2022) (3)
- TP5 triggers signal transduction involving mitogen activated protein kinases in monocytes. (1999) (3)
- Appetite Regulatory Peptides PYY 3-36 as an anti-obesity drug target (2005) (3)
- Improvement of wound healing by the development of ECM-inspired biomaterial coatings and controlled protein release (2021) (3)
- Proliferative Effect of Calcitonin Gene‐related Peptide is Induced by at least Five Proteins as Identified by Proteome Profiling (2007) (3)
- Recombinant expression and characterization of biologically active protein delta homolog 1. (2015) (3)
- Neuropeptide Y receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (2)
- Peptides as Modulators of Serpin Action (2015) (2)
- Receptor Signal Transduction Protocols, R.A.J. Challiss (Ed.). Humana Press (1997), ISBN: 0 896 03495 X (1997) (2)
- Hydrophobic contacts specifically contribute to peptide binding at the neuropeptide Y2 receptor (2016) (2)
- G Protein Preassembly Rescues Efficacy of W Toggle Mutations in Neuropeptide Y2 Receptor s (2018) (2)
- Large hydrophobic residues influence the secondary structure and receptor affinity of C-terminal neuropeptide Y analogues (1993) (2)
- Structure-Activity Relationships of Neuropeptide Y, (1992) (2)
- Protease-Triggered Release of Stabilized CXCL12 from Coated Scaffolds in an Ex Vivo Wound Model (2021) (2)
- The ring size of monocyclic ET‐1 controls selectivity and signaling efficiency at both endothelin receptor subtypes (2021) (2)
- Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists (1994) (2)
- Synthesis and Conformational Analysis by CD Spectroscopy of Lantibiotic Leader, Pro‐ and Pre‐Peptides (1994) (2)
- Arrestin-dependent internalization of rhodopsin-like G protein-coupled receptors (2021) (2)
- Comparative study of antibody titers induced by a peptide epitope conjugated with protein, lipopeptide, polyoxyethylene and polyoxyethylene-polystyrene graft copolymer (1991) (2)
- Highly Selective Y4 Receptor Antagonist Binds in an Allosteric Binding Pocket. (2021) (2)
- Quality assurance in computer validation systems postgraduate seminar on quality assurance in the pharmaceutical industry (1998) (2)
- Anti-Inflammatory Action of Keratinocyte-Derived Vaspin (1)
- Controlling toxicity of NPY-drug conjugates by different chemical linker structures (2016) (1)
- From Scientists to Scientists—Moving Angewandte into the Future (2020) (1)
- Carrier peptides: Promising tools for a broad range of applications (2002) (1)
- Systematic point mutation of high affinity analogue neuropeptide Y 1–4-Ahx-25–36 (1991) (1)
- Modern Methods in Protein- and Nucleic Acid Research. Herausgegeben von H. Tschesche. de Gruyter, Berlin, 1990. IX, 446 S., geb. DM 330.00. — ISBN 3-11-012275-8 (1992) (1)
- Selective mode of action of guanidine containing non peptides at human neuropeptide FF receptors (2012) (1)
- Inside Back Cover: Inhibition of Kallikrein‐Related Peptidases 7 and 5 by Grafting Serpin Reactive‐Center Loop Sequences onto Sunflower Trypsin Inhibitor‐1 (SFTI‐1) (ChemBioChem 8/2016) (2016) (1)
- Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in CKD: translational opportunities and challenges (1)
- Herbal drugs and phytopharmaceuticals: N.G. Bisset (Ed.), Medpharm GmbH, Scientific Publisher, Stuttgart, 1994, 568 pages, SFr. 298.00, ISBN 3-88763-025-4 (1995) (1)
- Photoaffinity labelling of calmodulin with a neuromodulin segment (1993) (1)
- Structure-Activity Relationship of Peptide-Derived Ligands at NPY Receptors (2004) (1)
- Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor (2021) (1)
- Effect of Deposition Temperature on the Structure, Mechanical, Electrochemical Evaluation, Degradation Rate and Peptides Adhesion of Mg and Si-Doped Hydroxyapatite Deposited on AZ31B Alloy (2023) (1)
- Orthogonal Peptide‐Templated Labeling Elucidates Lateral ETAR/ETBR Proximity and Reveals Altered Downstream Signaling (2021) (1)
- Structural Dynamics of the Ligand-Receptor Interaction of the Neuropeptide Y Receptor Type 2 (2016) (0)
- Fluorescent, Reagentless Biosensors for Phosphate: Altering Properties, Expanding Usefulness (0)
- IP accumulation assay (2022) (0)
- Cloning, Expression, andSequencing ofSqualene-Hopene Cyclase, aKeyEnzymeinTriterpenoid Metabolism (1992) (0)
- Discovery of novel small-molecule modulators of the human Y4receptor (2016) (0)
- Cover Image (2020) (0)
- Porphyrin-Mediated Photoinduced Conformational Changes to Human Serum Albumin at Physiological and Acidic pH (0)
- A palmitoylated ghrelin receptor ligand shows high metabolic invivo stability and bioavailability (2016) (0)
- Peptides on a New Path. Scientists from Leipzig Combine Biochemistry, Semi Conductor Physics and Theory (2006) (0)
- Vaspin inhibits kallikrein 7 by serpin mechanism (2013) (0)
- Structure Of Vaspin (2013) (0)
- A new generation of highly customized Mg alloy-based implants (2022) (0)
- Development of the first CGRP-antagonist with nanomolar affinity (2002) (0)
- Radiosynthesis, in vitro and in vivo evaluation of an 18F-labeled NPY analog for imaging of breast cancer by PET (2016) (0)
- Back Cover: Position and Length of Fatty Acids Strongly Affect Receptor Selectivity Pattern of Human Pancreatic Polypeptide Analogues (ChemMedChem 11/2014) (2014) (0)
- The wealth of cytomics. Résumé of the 19th Annual Meeting of the German Society for Cytometry (Deutsche Gesellschaft Für Zytometrie, DGfZ) (2010) (0)
- Ghrelin Binding at its G Protein-Coupled Receptor (2019) (0)
- [Directed evolution in drug and antibody development : From the Nobel Prize to broad clinical application]. (2019) (0)
- Neuropeptide Y5-Receptor II: Solution Structure and Dynamics of [31Ala,32Pro]-NPY (2008) (0)
- Peptides and Proteins. Von Shawn Doonan. (2004) (0)
- Histamine releasing activity as an undesired side effect in the development of peptide analogs: NPY- and magainin peptides (1993) (0)
- Spotlights on our sister journals: ChemPhysChem 7/2016. (2016) (0)
- Funktionelle Relevanz der Stop-Codon Mutation rs61757459 in Vaspin (SerpinA12) (2013) (0)
- PORCINE NEUROPEPTIDE Y BOUND TO DPC MICELLES (2001) (0)
- Tools to investigate ligand-binding interactions: Cys-depleted GHS-R1a (2016) (0)
- Discovery of novel small-molecule modulators of the human Y4 receptor (2016) (0)
- Highlight: Protein states with cell biological and medicinal relevance (2013) (0)
- Scientific Board of the FMP (2007) (0)
- Synthesis of the N-Terminus of the Cytochrome Subunit in the Photosynthetic Reaction Center from Purple Bacterium Rhodopseudomonas Viridis, (1992) (0)
- NPY ameliorates experimental autoimmune encephalitis (EAE): Y1 receptor specific induction of a Th2 shift in vivo * (2003) (0)
- Influence of deposition temperature on the structure and functional properties of Mg doped hydroxyapatite coatings deposited on manufactured AZ31B alloy substrates by RF magnetron sputtering (2023) (0)
- Exploring the translational potential of the NPY Y4 receptor for treating Type 1 Diabetes (2021) (0)
- Corrigendum to "Short-range cytokine gradients to mimic paracrine cell interactions in vitro" [J. Control. Release 224 (2016) 59-68]. (2016) (0)
- Book Review: Modern Methods in Protein‐ and Nucleic Acid Research. Edited by H. Tschesche (1992) (0)
- Ligand-Induced and -Independent Internalization of the Chemerin Receptor GPR1 (2021) (0)
- High yield in vitro folding of the Y2 receptor into bicelles for structural studies (2016) (0)
- Back Cover: Charge‐Compensated Metallacarborane Building Blocks for Conjugation with Peptides (ChemBioChem 4/2016) (2016) (0)
- Crystallization of a serpin with a insulin-sensitizing function (2011) (0)
- Asymmetric syntheses identify preferred stereochemistry in small molecule allosteric modulators of the neuropeptide Y4 receptor (2019) (0)
- Pinpointing the interaction site between semaphorin‐3A and its inhibitory peptide (2022) (0)
- Abstracts list 1 - Identity matters: Ggamma-type dictates efficacy of Gbetagamma signaling and cellular decisions (2018) (0)
- Specific mutations on the receptor‐binding interface of non‐visual arrestins differently affect recruitment by the NPY receptor family (2013) (0)
- NEUROPEPTIDE Y AND ITS RECEPTORS: MOLECULAR CHARACTERISATION AND INTERACTION (1997) (0)
- Photoactivatable Chemokines — Controlling Protein Activity by Light. (2014) (0)
- Solid-State NMR Studies on the Membrane Bound Acylated Peptide Hormone Ghrelin (2012) (0)
- Synthesis of Chemokines by Chemical Ligation (2017) (0)
- Front Cover: Carbaboranylation of Truncated C-Terminal Neuropeptide Y Analogue Leads to Full hY1 Receptor Agonism (ChemBioChem 21/2018) (2018) (0)
- Cyclized peptide amides: Characterization of intermediates during deprotection and systematic investigations of side-chain cyclization (1991) (0)
- Oxidative Folding of Peptides and Proteins. Edited by Johannes Buchner and Luis Moroder. (2009) (0)
- CB&DD Editorial Advisory Board (seventh in series) (2006) (0)
- Structural insights in the binding mode of neuropeptide Y at G protein coupled receptors and consequences for drug development (2020) (0)
- [ALA31, AIB32]-NEUROPEPTIDE Y (2000) (0)
- Sequence specific anti-Y1-receptor antibodies for the characterisation of the neuropeptide Y binding site (1995) (0)
- A new glycosylation deficiency syndrome (2011) (0)
- Peptide and protein hormones: Structure, regulation activity — A reference manual: Wolfgang Koenig. VCH, Weinheim, 1993. (1994) (0)
- Cover Picture: Semisynthesis and Characterization of the First Analogues of Pro‐Neuropeptide Y (ChemBioChem 5/2003) (2003) (0)
- Characterization of several NPY ligands with cloned murine NPY receptors: ICV administration of a selective Y5 agonist, D-TRP34NPY, induces obesity (2000) (0)
- Dynamics and Ligand Binding of the GHS G Protein-Coupled Receptor in Lipid Membranes (2018) (0)
- Molecular mechanism of the insulin sensitizing adipokine vaspin (2011) (0)
- Cover Picture: Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential (ChemMedChem 21/2016) (2016) (0)
- Experimental limits of the peptide library concept (1994) (0)
- Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels (2013) (0)
- Synthesis of Conformationally Restricted Peptides (1997) (0)
- Allosteric modulators to target the human Y4 receptor (2016) (0)
- Comparison of agonist and antagonist binding sites of the neuropeptide Y receptor 2 (2016) (0)
- The Chemerin Receptor CMKLR1 Requires Full‐Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase‐Based Binding Assay (2022) (0)
- Altering in the structure of Neuropeptide Y during the binding to the Y1 receptor investigated by NMR (2016) (0)
- Mammalian Peptide Hormones: Biosynthesis and Inhibition (2010) (0)
- Analogs of Interleukin 8 Containing non Proteinogenic Segments Show High Biological Activity (2006) (0)
- Different Y2 receptor antagonists share the same deep, hydrophobic binding pocket (2016) (0)
- Synaptic localisation of NPY Y1 receptors in the rat cingulate cortex (2007) (0)
- Boron Neutron Capture Therapy (BNCT): A rising hospital-based radiation modality on demand for a broad interdisciplinary collaboration to be implemented in Germany (2019) (0)
- Front Cover: Surface-Binding Peptide Facilitates Electricity-Driven NADPH-Free Cytochrome P450 Catalysis (ChemCatChem 3/2018) (2018) (0)
- Differential modulation of NPY receptor internalization and signaling by ligand modification (2016) (0)
- Receptor Binding Pocket 4 Y Two Hydrophobic Domains of the Human Pancreatic Polypeptide Is Recognized by Signal Transduction : (2014) (0)
- Influence of distinct motifs within the carboxyl-terminusof the human neuropeptide Y4 receptor on internalization and arrestin3 recruitment (2016) (0)
- Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor (2018) (0)
- Peptides and Proteins. By Shawn Doonan. (2004) (0)
- Th 1 Responses In Vivo Receptor-Specific Inhibition of Autoreactive 1 Autoimmune Encephalomyelitis : NPY Neuropeptide Y ( NPY ) Suppresses Experimental (2003) (0)
- ned sulfated oligohyaluronans reveal structural e ff ects , diversity and thermodynamics of GAG – protein binding † (2019) (0)
- Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor. (2021) (0)
- Biotinylated peptides as substrates in enzymic reactions (1991) (0)
- For everybody who is involved in solid-phase synthesis: Solid-Phase Synthesis - A Practical Guide By Steven A, Kates and Feman do Alberico. Marcel Dekker, New York 2000. 826 pp., hardcover, 250.-5 ISBN 0-8247-0359-6 (2001) (0)
- Epileptiform Activity in Rat Hippocampal Slices Excitation in Proximal Subiculum, But Not (2015) (0)
- Anchor‐linked intermediates in peptide amide synthesis are caused by dimeric anchors on the solid supports (1995) (0)
- Energetic electron assisted synthesis of highly tunable temperature-responsive collagen/elastin gels for cyclic actuation: macroscopic switching and molecular origins (2019) (0)
- Analysis of Receptor‐Ligand Interaction (2008) (0)
- Protease-Triggered Release of Stabilized CXCL12 from Coated Biomaterials for Improved Implant Integration and Wound Healing (2021) (0)
- Structure and dynamic signaling of the Y2 receptor (2016) (0)
- Active contractions in single suspended epithelial cells (2013) (0)
- Human thymopoietin beta-fragments: synthesis and antibody studies (1999) (0)
- Structural dynamics of the ligand–receptor interaction of the neuropeptide Y receptor type 2 (2016) (0)
- Investigation of Structural Changes Upon Ligand Binding of the Methylated Neuropeptide Y Receptor Type 2 (2011) (0)
- Chillin' with NPY (2016) (0)
- Frontiers in Medicinal Chemistry 2005 (2005) (0)
- [ALA31,PRO32]-PNPY BOUND TO DPC MICELLES (2002) (0)
- Inside Cover: The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer Membranes (Angew. Chem. Int. Ed. 52/2020) (2020) (0)
- Research and development of vaccines and pharmaceuticals from biotechnology — A guide to effective project management, patenting and product registration: Jens-Peter Gregersen, 172 pp., VCH Weinheim, 1994, ISBN 3-527-30059-7 (1997) (0)
This paper list is powered by the following services:
Other Resources About Annette Beck-Sickinger
What Schools Are Affiliated With Annette Beck-Sickinger?
Annette Beck-Sickinger is affiliated with the following schools:
